BFF Bank Valuation

Is 0RON undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0RON when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0RON (€8.95) is trading below our estimate of fair value (€16.29)

Significantly Below Fair Value: 0RON is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0RON?

Key metric: As 0RON is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0RON. This is calculated by dividing 0RON's market cap by their current earnings.
What is 0RON's PE Ratio?
PE Ratio6.8x
Earnings€246.54m
Market Cap€1.68b

Price to Earnings Ratio vs Peers

How does 0RON's PE Ratio compare to its peers?

The above table shows the PE ratio for 0RON vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.3x
BUR Burford Capital
11.6x24.6%UK£2.4b
EQLS Equals Group
27.3x32.0%UK£222.6m
DUKE Duke Capital
10.1x18.0%UK£116.7m
LIT Litigation Capital Management
20.3x18.2%UK£134.2m
0RON BFF Bank
6.8x2.7%€1.7b

Price-To-Earnings vs Peers: 0RON is good value based on its Price-To-Earnings Ratio (6.8x) compared to the peer average (17.3x).


Price to Earnings Ratio vs Industry

How does 0RON's PE Ratio compare vs other companies in the GB Diversified Financial Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
NBS Nationwide Building Society
0.9xn/aUS$1.51b
No more companies available in this PE range
0RON 6.8xIndustry Avg. 13.3xNo. of Companies3PE01020304050+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0RON is good value based on its Price-To-Earnings Ratio (6.8x) compared to the UK Diversified Financial industry average (13.3x).


Price to Earnings Ratio vs Fair Ratio

What is 0RON's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0RON PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio6.8x
Fair PE Ratio15.5x

Price-To-Earnings vs Fair Ratio: 0RON is good value based on its Price-To-Earnings Ratio (6.8x) compared to the estimated Fair Price-To-Earnings Ratio (15.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0RON forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€8.95
€10.98
+22.6%
12.8%€13.50€8.70n/a8
Nov ’25€9.07
€11.14
+22.8%
11.6%€13.50€9.00n/a8
Oct ’25€9.70
€11.20
+15.5%
10.7%€13.50€9.50n/a8
Sep ’25€9.80
€11.20
+14.3%
10.7%€13.50€9.50n/a8
Aug ’25€10.25
€11.20
+9.3%
10.7%€13.50€9.50n/a8
Jul ’25€9.07
€10.88
+20.0%
9.3%€12.00€8.60n/a8
Jun ’25€9.13
€10.88
+19.1%
9.3%€12.00€8.60n/a8
May ’25€12.03
€13.54
+12.5%
9.9%€16.00€11.40n/a8
Apr ’25€12.40
€12.63
+1.8%
9.3%€15.00€11.20n/a8
Mar ’25€10.90
€12.26
+12.5%
6.4%€13.00€11.20n/a7
Feb ’25€10.10
€11.96
+18.4%
7.6%€13.00€10.60n/a7
Jan ’25€10.33
€11.96
+15.8%
7.6%€13.00€10.60n/a7
Dec ’24€10.57
€11.60
+9.7%
7.9%€13.00€10.50n/a7
Nov ’24€9.30
€11.60
+24.8%
7.9%€13.00€10.50€9.077
Oct ’24€9.48
€11.67
+23.2%
7.6%€13.00€10.50€9.707
Sep ’24€9.88
€11.53
+16.7%
6.4%€12.70€10.50€9.807
Aug ’24€10.17
€11.31
+11.3%
6.9%€12.70€10.50€10.257
Jul ’24€10.06
€10.73
+6.6%
8.1%€12.00€9.00€9.077
Jun ’24€9.59
€10.49
+9.3%
6.9%€11.50€9.00€9.137
May ’24€8.74
€10.41
+19.1%
7.1%€11.50€9.00€12.037
Apr ’24€9.18
€10.41
+13.5%
7.1%€11.50€9.00€12.407
Mar ’24€9.39
€10.13
+7.9%
9.2%€11.50€8.70€10.907
Feb ’24€8.77
€9.69
+10.5%
7.7%€10.50€8.70€10.107
Jan ’24€7.43
€9.02
+21.4%
9.5%€10.50€7.80€10.336
Dec ’23€7.37
€9.02
+22.4%
9.5%€10.50€7.80€10.576
Nov ’23€7.20
€8.97
+24.6%
9.3%€10.50€7.80€9.306

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies